SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-373454
Filing Date
2015-11-10
Accepted
2015-11-10 16:13:03
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d79142d10q.htm 10-Q 574239
2 EXHIBIT 31.1 d79142dex311.htm EX-31.1 6044
3 EXHIBIT 31.2 d79142dex312.htm EX-31.2 5881
4 EXHIBIT 32.1 d79142dex321.htm EX-32.1 4194
  Complete submission text file 0001193125-15-373454.txt   2698256

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20150930.xml EX-101.INS 387325
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20150930.xsd EX-101.SCH 35997
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20150930_cal.xml EX-101.CAL 50896
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20150930_def.xml EX-101.DEF 106266
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20150930_lab.xml EX-101.LAB 267873
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20150930_pre.xml EX-101.PRE 193589
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 151219078
SIC: 2834 Pharmaceutical Preparations